Gene Therapy for Cardiomyocyte Renewal: Cell Cycle, a Potential Therapeutic Target
Authors:
- 13 December 2022
- journal article
- research article
- Published by Springer Nature in Molecular Diagnosis & Therapy
- Vol. 27 (2) , 129-140
Abstract
Heart disease is the primary cause of death worldwide. Even though extensive research has been done, and many pharmacological and surgical treatments have been introduced to treat heart disease, the mortality rate still remains high. Gene therapy is widely used to understand molecular mechanisms of myocardial infarction and to treat cardiomyocyte loss. It was reported that adult cardiomyocytes proliferate at a very low rate; thus, targeting their proliferation has become a new regenerative therapeutic approach. Currently, re-activating cardiomyocyte proliferation appears to be one of the most promising methods to promote adult cardiomyocyte renewal. In this article, we highlight gene therapeutic targets of cell proliferation presently being pursued to re-activate the cell cycle of cardiomyocytes, including cell cycle regulators, transcription factors, microRNAs, signal transduction, and other contributing factors. We also summarize gene delivery vectors that have been used in cardiac research and major challenges to be overcome in the translation to the clinical approach and future directions.Keywords
Funding Information
- National Institute of Health (R01 HL142627, HL156855)
- American Heart Association (20TPA35490001)
This publication has 133 references indexed in Scilit:
- miR-15 Family Regulates Postnatal Mitotic Arrest of CardiomyocytesCirculation Research, 2011
- Knockdown of Cyclin-dependent Kinase Inhibitors Induces Cardiomyocyte Re-entry in the Cell CycleJournal of Biological Chemistry, 2011
- Transient Regenerative Potential of the Neonatal Mouse HeartScience, 2011
- Coexpression of VEGF and angiopoietin-1 promotes angiogenesis and cardiomyocyte proliferation reduces apoptosis in porcine myocardial infarction (MI) heartProceedings of the National Academy of Sciences, 2011
- Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemiaNature, 2010
- Evidence for Cardiomyocyte Renewal in HumansScience, 2009
- Embryonic Stem Cell-Specific miR302-367 Cluster: Human Gene Structure and Functional Characterization of Its Core PromoterMolecular and Cellular Biology, 2008
- Gata4 is required for maintenance of postnatal cardiac function and protection from pressure overload-induced heart failureProceedings of the National Academy of Sciences, 2006
- Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8Molecular Therapy, 2006
- Cardiac-Specific Deletion of Gata4 Reveals Its Requirement for Hypertrophy, Compensation, and Myocyte ViabilityCirculation Research, 2006